Abstract: AIM : To investigate the clinical value of botulinum toxin type A in the treatment of children with cerebral palsy.METHODS: The 86 cases of lower limb spasticity in children with cerebral palsy were randomly divided into two groups, treatment group (n=43) and control group (n=43). The control group was given Vojta training, and the treatment group was also given botulinum toxin type A. The muscle spasms, motor function and activities of daily living in 2 groups were observed and compared. RESULTS:The score of composite spasticity scale in the treatment group after treatment was significantly lower than the control group (P<0.05); the D district E district scores of gross motor function measure in the treatment group after treatment were significantly higher than the control group(P<0.05); the score of activities of daily living in the treatment group after treatment was significantly higher than the control group (P<0.05). CONCLUSION: Botulinum toxin type A can efficiently relieve muscle spasms, and promote recovery of their motor function.

Key words: cerebral palsy, muscle spasms, botulinum toxin type A